GlassScriptPhysician profile
Rodney B Ashworth
NPI 1356377907
$24,265.49
in general payments reported to CMS, 2019-2025
27 companies · $783 in 2025
The $783 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $270 · 2021: $809 · 2022: $533 · 2023: $634 · 2024: $512 · 2025: $783.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,929.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $20,842.67 | 2019-2023 | Da Vinci Surgical System |
| Integra Lifesciences Corporation | $715.83 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Davol INC. | $574.46 | 2022-2025 | Phasix Mesh, Bard 3dmax Mesh |
| Tela Bio, INC. | $407.59 | 2019-2022 | |
| Abbott Laboratories | $328.66 | 2023-2024 | Octrode |
| Kerecis Limited | $276.25 | 2022-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Allergan, INC. | $250.20 | 2019-2021 | |
| Medical Device Business Services, INC. | $139.37 | 2025 | Vistaseal |
| Medtronic, INC. | $129.73 | 2021-2025 | Ligasure |
| Takeda Pharmaceuticals U.S.A., INC. | $87.79 | 2020-2025 | Gattex |
| Teleflex LLC | $85.46 | 2019-2025 | Deknatel |
| Ethicon US, LLC | $54.00 | 2019-2025 | Endopath |
| Coopersurgical, INC. | $40.91 | 2019-2021 | |
| Mimedx Group, INC. | $37.11 | 2025 | |
| Innocoll Pharmaceuticals Limited | $34.47 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $34.18 | 2019-2021 | |
| Conmed Corporation | $33.33 | 2019 | |
| W. L. Gore & Associates, INC. | $28.14 | 2022-2024 | Gore Enform Preperitoneal Biomaterial |
| Boston Scientific Corporation | $27.74 | 2025 | Spyglass Discover |
| Pacira Pharmaceuticals Incorporated | $26.89 | 2020-2021 | |
| Dilon Technologies, INC. | $22.42 | 2025 | Hemoblast Bellows |
| Mallinckrodt Hospital Products INC. | $20.81 | 2020 | |
| Henry Schein, INC. | $16.66 | 2025 | |
| Smith+Nephew, INC. | $16.35 | 2025 | Versajet |
| Shire North American Group INC | $13.69 | 2019 | |
| Innovation Technologies INC | $13.65 | 2023 | Irrisept |
| Heron Therapeutics, INC. | $7.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodney Ashworth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.